Case report: Fatal cerebral herniation caused by hypoglycemic due to mistaking glibenclamide in children

Chunlan Song1, Wanyu Jia1, Shengli Shi1

  • 1Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou, China.

Insights

A child in China accidentally ingested glibenclamide, a diabetes medication, leading to fatal hypoglycemia and brain herniation. This case highlights the critical need for awareness of accidental drug ingestion in children.

Area of Science:

  • Pediatrics
  • Toxicology
  • Endocrinology

Background:

  • Glibenclamide is a common hypoglycemic agent used in China.
  • Increased prevalence of diabetes and a significant population of 'left-behind' children in China raise concerns for accidental medication ingestion.
  • Accidental ingestion of medications by children is a serious public health issue.

Observation:

  • A case report details a child who mistakenly ingested glibenclamide.
  • The child developed severe hypoglycemia, leading to cerebral edema and brain herniation.
  • This represents the first reported pediatric fatality from glibenclamide-induced brain herniation in China.

Findings:

  • Accidental glibenclamide ingestion can cause severe hypoglycemia in children.
  • Hypoglycemia can rapidly progress to life-threatening complications like cerebral edema and brain herniation.
  • Delayed recognition and treatment of hypoglycemia increase mortality risk.

Implications:

  • Clinicians must consider accidental glibenclamide ingestion in children presenting with unexplained seizures and coma.
  • Detailed medical history is crucial for diagnosing non-obvious causes of pediatric emergencies.
  • Prompt administration of high-concentration glucose is vital for managing hypoglycemia and preventing severe neurological damage.
  • Pediatricians should maintain a high index of suspicion for accidental medication exposure in children with altered consciousness.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...